FWM
TEVA icon

Filbrandt Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Filbrandt Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$0 Hold
20
– – ﹤0.01% 255
2021
Q2 		$0 Buy
+20
New +$212 ﹤0.01% 196
2020
Q2 		– Sell
-147
Closed -$1K – 454
2020
Q1 		$1K Buy
147
+1
+0.7% +$10 ﹤0.01% 226
2019
Q4 		$1K Buy
+146
New +$1.3K ﹤0.01% 177

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Filbrandt Wealth Management's TEVA Position: Q3 2021 in Review

Filbrandt Wealth Management held its Teva Pharmaceuticals (TEVA) position steady in Q3 2021 at 20 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Filbrandt Wealth Management first reported a position in TEVA in Q4 2019 and has held it in 4 quarters since. The position peaked at $1K in Q1 2020. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

  • Filbrandt Wealth Management held 20 shares of Teva Pharmaceuticals worth $0 as of Q3 2021.
  • Filbrandt Wealth Management left its Teva Pharmaceuticals share count unchanged in Q3 2021.
  • Teva Pharmaceuticals made up ﹤0.01% of Filbrandt Wealth Management's portfolio in Q3 2021, its #255 holding.
  • Filbrandt Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
  • Filbrandt Wealth Management's Teva Pharmaceuticals position peaked at $1K in Q1 2020.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.